3i Group

Type

Private equity

Status

Active

Location

London, United Kingdom

Total investments

480

Average round size

27M

Portfolio companies

335

Rounds per year

6.08

Lead investments

100

Follow on index

0.30

Exits

181

Stages of investment
SeedPrivate EquityEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyInternetSoftwareInformation TechnologyHealth CareEnterprise SoftwareManufacturingMedicalPharmaceuticalWireless

Summary

3i Group is the famous VC, which was founded in 1945. The main department of described VC is located in the London. The venture was found in Europe in United Kingdom.

The common things for fund are deals in the range of 10 - 50 millions dollars. When the investment is from 3i Group the average startup value is 100-500 millions dollars. The increased amount of exits for fund were in 2011. The high activity for fund was in 2004. Despite it in 2019 the fund had an activity. Considering the real fund results, this VC is 7 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this 3i Group performs on 9 percentage points more the average number of lead investments. The fund is generally included in 7-12 deals every year.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the 3i Group, startups are often financed by Venrock, Scottish Equity Partners, Intel Capital. The meaningful sponsors for the fund in investment in the same round are Matrix Partners, Atlas Venture, Amadeus Capital Partners. In the next rounds fund is usually obtained by Oak Investment Partners, Gimv, Amadeus Capital Partners.

The overall number of key employees were 40.

Among the most popular fund investment industries, there are E-Commerce, Medical. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Collins Aerospace, Quintiles, Vonage.

Show more

Investor highlights

Industry focus
Consumer/RetailHealthcareManufacturingEnergyTelecommunications Show 3 more
Geo focus
AlbaniaAustriaBelgiumBosnia and HerzegovinaBulgaria Show 38 more
Check size
54M — 429M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
EUR 2500000000

Analytics

Total investments
480
Lead investments
100
Exits
181
Rounds per year
6.08
Follow on index
0.30
Investments by industry
  • Software (117)
  • Manufacturing (75)
  • Biotechnology (59)
  • Information Technology (53)
  • Health Care (52)
  • Show 264 more
Investments by region
  • United States (202)
  • United Kingdom (121)
  • France (35)
  • Germany (38)
  • Netherlands (2)
  • Show 20 more
Peak activity year
2004
Number of Unicorns
3
Number of Decacorns
5
Number of Minotaurs
2

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
27
Avg. valuation at time of investment
148M
Group Appearance index
0.70
Avg. company exit year
17
Avg. multiplicator
5.33
Strategy success index
0.60

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Santhera Pharmaceuticals 20 Dec 2005 Biotechnology, Health Care, Pharmaceutical Early Stage Venture 18M Switzerland, Basel-Country
Zygon 29 Aug 1999 Early Stage Venture 6M England, London, United Kingdom

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.